All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Study: Clopidogrel Monotherapy Linked to Lower MACE and Bleeding Risks vs. Aspirin After PCI

8d ago· 2 min readenNews

Summary

A nationwide cohort study published in JACC: Asia found that among stable patients who underwent PCI, transitioning to clopidogrel monotherapy was associated with lower risks of major adverse cardiovascular events (MACE) and major bleeding compared with aspirin monotherapy. The study, led by Jun Hwan Cho, MD, used the Korean nationwide claims and health examination database to analyze long-term outcomes from 2009 to 2019.

Source

Twitter / XStudy: Clopidogrel Monotherapy Linked to Lower MACE and Bleeding Risks vs. Aspirin After PCIacc.org

Key quotes

· 1 pulled
Clopidogrel monotherapy was associated with lower risks of major adverse cardiovascular events (MACE) and major bleeding compared with aspirin monotherapy among stable patients post PCI, according to a nationwide cohort study published June 15 in JACC: Asia.
Snippet from the RSS feed
Clopidogrel monotherapy was associated with lower risks of major adverse cardiovascular events (MACE) and major bleeding compared with aspirin monotherapy among stable patients post PCI, according to a nationwide cohort study published June 15 in JACC: As

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.